Alerts

Health professionals and consumers are advised that sponsor, Sorin Group Australia, in consultation with the TGA, has issued a hazard alert for Isoline defibrillation leads.

Updated information regarding patient follow-up for the ABGII Modular Femoral Stem and Modular Neck hip replacement system

PIP breast implants: Consumer questions & answers

GlaxoSmithKline (GSK) and Alphapharm, in consultation with the TGA, are undertaking a voluntary recall of several batches of Ventolin and Asmol inhalers due to a fault in the delivery mechanism of a small number of inhalers within each batch. This can lead to less than the full dose being delivered for each puff.

We are recalling all batches of Muscletech Hydroxystim capsules due to the presence of the banned substance DMAA. Consult your doctor if you have concerns.

Six batches of Infanrix hexa vaccine are being recalled due to potential contamination with Bacillus cereus. Consult your doctor if you have concerns.

Some batches of the Typhim Vi Vaccine are being recalled due to lower antigen content. Consult your doctor if you have concerns.

We are recalling Serenace (haloperidol) 0.5mg tablets from batch BJ431 due to mould contamination. Consult your doctor if you have concerns.

List of all alerts regarding ABGII Modular Femoral Stem and Modular Neck - hip replacement system recall

Therapeutic Goods Administration (TGA) advises that Stryker Australia Pty Ltd is recalling the ABGII Modular Femoral Stem and Modular Neck system used in hip replacements

The Therapeutic Goods Administration (TGA) advises that the R3 metal liner component of the R3 acetabular system (used in hip replacements) is being recalled by the Australian sponsor, Smith & Nephew Surgical Pty Ltd.

The Therapeutic Goods Administration (TGA) advises that Endeavour Industries brand Quad (4 X Point) Walking Sticks, Product Code X640, are being recalled.

CSL Biotherapies is recalling the batch 3450700309 of Albumex 4, due to the presence of ethylene glycol

Some batches of Albumex manufactured prior to 25 January 2012 may be contaminated with very low levels of ethylene glycol

Information on the management of issues related to the recall of PIP silicone gel breast implants

Information on the management of issues related to the recall of PIP silicone gel breast implants

The TGA advises that while PIP breast implants were recalled due to the use of unauthorised silicone, current evidence does not support routine removal in patients without symptoms, and individuals are encouraged to seek medical advice if concerned.

At the time of writing, the TGA has been advised that approximately 9,054 PIP breast implants have been implanted by surgeons between 2002 and 2010. In April 2010 non-implanted PIP breast implants were recalled from the Australian marketplace.